Morgan Health, a business unit of JPMorgan Chase & Co. (NYSE: JPM) focused on improving the quality, equity, and affordability of employer-sponsored health care, announced a $25 million investment in Kindbody, a leading fertility clinic network and global family-building benefits provider for employers providing the full spectrum of reproductive care from preconception to postpartum through menopause.
Kindbody’s Board of Directors will be joined by Dr. Cheryl Pegus, a Managing Director at Morgan Health Ventures.
Kindbody’s model is unique in that it is the only provider of family-building benefits to employers that own and operate reproductive clinics.
Employers save 25%-30% by contracting directly with the organization to deliver full virtual and in-person care to their employees.
Kindbody is uniquely positioned as a direct supplier of care to reduce costs, improve the patient experience, and achieve better health outcomes.
Morgan Health is a division of JPMorgan Chase dedicated to improve employer-sponsored health care. Morgan Health is seeking to improve the quality, equity, and affordability of employer-sponsored health care for JPMorgan Chase employees, their families, and the U.S. health system through investments and the growth of responsible care.
Dan Mendelson, CEO of Morgan Health, leads the company and reports to Peter Scher, Vice Chairman of JPMorgan Chase & Co. and a member of the firm’s Operating Committee.
Kindbody is a technology-driven fertility clinic network and employer-provided family-building benefits provider that provides both virtual and in-person services.
Kindbody is a dependable fertility benefits supplier for 112 prominent businesses, representing over 2.4 million people.
Many thousands more people receive fertility care directly from Kindbody at signature clinics, mobile clinics, and partner clinics across the country.
Kindbody provides a seamless, integrated experience with greater health outcomes at a cheaper cost, making fertility care more reasonable and accessible for all.
Kindbody has received $315 million in funding from a group of renowned investors that includes Perceptive Advisors, Morgan Health, GV (previously Google Ventures), RRE Ventures, Claritas Health Ventures, Rock Springs Capital, NFP Ventures, Whatif Ventures, and TQ Ventures.
